KATZAROFF JAMES C 4/A
4/A · GlobeStar Therapeutics Corp · Filed Apr 4, 2023
Insider Transaction Report
Form 4/AAmended
KATZAROFF JAMES C
Executive officer
Transactions
- Other
Common stock
2023-04-03$0.01/sh+7,042,253$50,000→ 17,042,253 total - Award
Options
2023-02-24+35,000,000→ 65,000,000 totalExercise: $0.01From: 2023-08-24Exp: 2028-02-24→ Common stock (35,000,000 underlying) - Award
Options
2021-05-12+30,000,000→ 30,000,000 totalExercise: $0.03From: 2021-05-12Exp: 2023-05-12→ Common stock (30,000,000 underlying)
Footnotes (3)
- [F1]Shares acquired pursuant to conversion of debt of $50,000.
- [F2]Options vest 50% when granted and balance ratably on a daily basis during the 24 month period commencing on date of grant.
- [F3]Vested Options are exercisable 6 months after date of grant and thereafter until 5 years after the date of grant.